Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans

References

• Tartour E, Mathiot C, Fridman WH. Current status of interleukin-2 therapy in cancer. Biomed Pharmacother 1992; 46:473 - 84; http://dx.doi.org/10.1016/0753-3322(92)90005-R; PMID: 1306361
   PubMed Web of Science ®Google Scholar
• Andersen P, Doherty TM, Pai M, Weldingh K. The prognosis of latent tuberculosis: can disease be predicted?. Trends Mol Med 2007; 13:175 - 82; http://dx.doi.org/10.1016/j.molmed.2007.03.004; PMID: 17418641
   PubMed Web of Science ®Google Scholar
• Zeremski M, Petrovic LM, Talal AH. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepat 2007; 14:675 - 87; PMID: 17875002
   PubMed Web of Science ®Google Scholar
• Adotevi O, Vingert B, Freyburger L, Shrikant P, Lone YC, Quintin-Colonna F, Haicheur N, Amessou M, Herbelin A, Langlade-Demoyen P, et al. B subunit of Shiga toxin-based vaccines synergize with alpha-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity. J Immunol 2007; 179:3371 - 9; PMID: 17709554
   PubMed Web of Science ®Google Scholar
• Pere H, Montier Y, Bayry J, Quintin-Colonna F, Merillon N, Dransart E, Badoual C, Gey A, Ravel P, Marcheteau E, et al. A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens. Blood 2011; 118:4853 - 62; http://dx.doi.org/10.1182/blood-2011-01-329656; PMID: 21908423
   PubMed Web of Science ®Google Scholar
• De Carli M, D’Elios MM, Zancuoghi G, Romagnani S, Del Prete G. Human Th1 and Th2 cells: functional properties, regulation of development and role in autoimmunity. Autoimmunity 1994; 18:301 - 8; http://dx.doi.org/10.3109/08916939409009532; PMID: 7858116
   PubMed Web of Science ®Google Scholar
• Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361:888 - 98; http://dx.doi.org/10.1056/NEJMra0707449; PMID: 19710487
   PubMed Web of Science ®Google Scholar
• Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, Migaud M, Israel L, Chrabieh M, Audry M, et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011; 332:65 - 8; http://dx.doi.org/10.1126/science.1200439; PMID: 21350122
   PubMed Web of Science ®Google Scholar
• Groux H, O’Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MGA. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389:737 - 42; http://dx.doi.org/10.1038/39614; PMID: 9338786
   PubMed Web of Science ®Google Scholar
• Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM, O’Garra A. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195:603 - 16; http://dx.doi.org/10.1084/jem.20011629; PMID: 11877483
   PubMed Web of Science ®Google Scholar
• Battaglia M, Stabilini A, Draghici E, Gregori S, Mocchetti C, Bonifacio E, Roncarolo MG. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 2006; 55:40 - 9; http://dx.doi.org/10.2337/diabetes.55.01.06.db05-0613; PMID: 16380475
   PubMed Web of Science ®Google Scholar
• Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421:388 - 92; http://dx.doi.org/10.1038/nature01315; PMID: 12540904
   PubMed Web of Science ®Google Scholar
• Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe AH, Berry G, DeKruyff RH, Umetsu DT. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002; 8:1024 - 32; http://dx.doi.org/10.1038/nm745; PMID: 12145647
   PubMed Web of Science ®Google Scholar
• Cottrez F, Hurst SD, Coffman RL, Groux H. T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 2000; 165:4848 - 53; PMID: 11046008
   PubMed Web of Science ®Google Scholar
• Walter S, Weinschenk T, Stenzl A, Zdrojowy R, Pluzanska A, Szczylik C, Staehler M, Brugger W, Dietrich PY, Mendrzyk R, et al. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med 2012; 18:1254 - 61; http://dx.doi.org/10.1038/nm.2883; PMID: 22842478
   PubMed Web of Science ®Google Scholar
• Mascarell L, Lombardi V, Louise A, Saint-Lu N, Chabre H, Moussu H, Betbeder D, Balazuc AM, Van Overtvelt L, Moingeon P. Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells. J Allergy Clin Immunol 2008; 122:603 - 9, e5; http://dx.doi.org/10.1016/j.jaci.2008.06.034; PMID: 18774396
   PubMed Web of Science ®Google Scholar
• Jarnicki AG, Conroy H, Brereton C, Donnelly G, Toomey D, Walsh K, Sweeney C, Leavy O, Fletcher J, Lavelle EC, et al. Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics. J Immunol 2008; 180:3797 - 806; PMID: 18322186
   PubMed Web of Science ®Google Scholar
• Sun JB, Czerkinsky C, Holmgren J. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit. Scand J Immunol 2010; 71:1 - 11; http://dx.doi.org/10.1111/j.1365-3083.2009.02321.x; PMID: 20017804
   PubMed Web of Science ®Google Scholar
• Zygmunt BM, Rharbaoui F, Groebe L, Guzman CA. Intranasal immunization promotes th17 immune responses. J Immunol 2009; 183:6933 - 8; http://dx.doi.org/10.4049/jimmunol.0901144; PMID: 19890060
   PubMed Web of Science ®Google Scholar
• Chauvat A, Benhamouda N, Loison E, Gougeon ML, Gey A, Levionnois E, Ravel P, Abitbol V, Roncelin S, Marcheteau E, et al. Pitfalls in anti-influenza T cell detection by Elispot using thimerosal containing pandemic H1N1 vaccine as antigen. J Immunol Methods 2012; 378:81 - 7; http://dx.doi.org/10.1016/j.jim.2012.02.008; PMID: 22366633
   PubMed Web of Science ®Google Scholar
• Bercovici N, Haicheur N, Massicard S, Vernel-Pauillac F, Adotevi O, Landais D, Gorin I, Robert C, Prince HM, Grob JJ, et al. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients. J Immunother 2008; 31:101 - 12; http://dx.doi.org/10.1097/CJI.0b013e318159f5ba; PMID: 18157017
   PubMed Web of Science ®Google Scholar
• Haicheur N, Escudier B, Dorval T, Negrier S, De Mulder PH, Dupuy JM, Novick D, Guillot T, Wolf S, Pouillart P, et al. Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients. Clin Exp Immunol 2000; 119:28 - 37; http://dx.doi.org/10.1046/j.1365-2249.2000.01112.x; PMID: 10606961
   PubMed Web of Science ®Google Scholar
• Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ, Hoff ST, Andersen P, Reed SG, Morris SL, et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007; 13:843 - 50; http://dx.doi.org/10.1038/nm1592; PMID: 17558415
   PubMed Web of Science ®Google Scholar
• Peretz Y, Ndongala ML, Boulet S, Boulassel MR, Rouleau D, Côté P, Longpré D, Routy JP, Falutz J, Tremblay C, et al. Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progression. Clin Immunol 2007; 124:57 - 68; http://dx.doi.org/10.1016/j.clim.2007.04.004; PMID: 17521962
   PubMed Web of Science ®Google Scholar
• Gazagne A, Claret E, Wijdenes J, Yssel H, Bousquet F, Levy E, Vielh P, Scotte F, Goupil TL, Fridman WH, et al. A Fluorospot assay to detect single T lymphocytes simultaneously producing multiple cytokines. J Immunol Methods 2003; 283:91 - 8; http://dx.doi.org/10.1016/j.jim.2003.08.013; PMID: 14659902
   PubMed Web of Science ®Google Scholar
• Rebhahn JA, Bishop C, Divekar AA, Jiminez-Garcia K, Kobie JJ, Lee FE, Maupin GM, Snyder-Cappione JE, Zaiss DM, Mosmann TR. Automated analysis of two- and three-color fluorescent Elispot (Fluorospot) assays for cytokine secretion. Comput Methods Programs Biomed 2008; 92:54 - 65; http://dx.doi.org/10.1016/j.cmpb.2008.06.002; PMID: 18644656
   PubMed Web of Science ®Google Scholar
• McKinstry KK, Strutt TM, Swain SL. Hallmarks of CD4 T cell immunity against influenza. J Intern Med 2011; 269:507 - 18; http://dx.doi.org/10.1111/j.1365-2796.2011.02367.x; PMID: 21362069
   PubMed Web of Science ®Google Scholar
• Karulin AY, Hesse MD, Tary-Lehmann M, Lehmann PV. Single-cytokine-producing CD4 memory cells predominate in type 1 and type 2 immunity. J Immunol 2000; 164:1862 - 72; PMID: 10657635
   PubMed Web of Science ®Google Scholar
• Fujio K, Okamura T, Yamamoto K. The Family of IL-10-secreting CD4+ T cells. Adv Immunol 2010; 105:99 - 130; http://dx.doi.org/10.1016/S0065-2776(10)05004-2; PMID: 20510731
   PubMed Web of Science ®Google Scholar
• Pot C, Apetoh L, Kuchroo VK. Type 1 regulatory T cells (Tr1) in autoimmunity. Semin Immunol 2011; 23:202 - 8; http://dx.doi.org/10.1016/j.smim.2011.07.005; PMID: 21840222
   PubMed Web of Science ®Google Scholar
• Gagliani N, Magnani CF, Huber S, Gianolini ME, Pala M, Licona-Limon P, Guo B, Herbert DR, Bulfone A, Trentini F, et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med 2013; 19:739 - 46; http://dx.doi.org/10.1038/nm.3179; PMID: 23624599
   PubMed Web of Science ®Google Scholar
• Astier AL, Meiffren G, Freeman S, Hafler DA. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J Clin Invest 2006; 116:3252 - 7; http://dx.doi.org/10.1172/JCI29251; PMID: 17099776
   PubMed Web of Science ®Google Scholar
• Bacchetta R, Bigler M, Touraine JL, Parkman R, Tovo PA, Abrams J, de Waal Malefyt R, de Vries JE, Roncarolo MG. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 1994; 179:493 - 502; http://dx.doi.org/10.1084/jem.179.2.493; PMID: 7905018
   PubMed Web of Science ®Google Scholar
• Huurman VA, Velthuis JH, Hilbrands R, Tree TI, Gillard P, van der Meer-Prins PM, Duinkerken G, Pinkse GG, Keymeulen B, Roelen DL, et al. Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation. Am J Transplant 2009; 9:382 - 8; http://dx.doi.org/10.1111/j.1600-6143.2008.02479.x; PMID: 19067657
   PubMed Web of Science ®Google Scholar
• VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, Chin T, Kusaka S, Geissler F, Pelletier RP, Orosz CG. Human allograft acceptance is associated with immune regulation. J Clin Invest 2000; 106:145 - 55; http://dx.doi.org/10.1172/JCI9171; PMID: 10880058
   PubMed Web of Science ®Google Scholar
• Connerotte T, Van Pel A, Godelaine D, Tartour E, Schuler-Thurner B, Lucas S, Thielemans K, Schuler G, Coulie PG. Functions of Anti-MAGE T-cells induced in melanoma patients under different vaccination modalities. Cancer Res 2008; 68:3931 - 40; http://dx.doi.org/10.1158/0008-5472.CAN-07-5898; PMID: 18483279
   PubMed Web of Science ®Google Scholar
• Nouri-Aria KT, Durham SR. Regulatory T cells and allergic disease. Inflamm Allergy Drug Targets 2008; 7:237 - 52; http://dx.doi.org/10.2174/187152808786848405; PMID: 19075789
   PubMedGoogle Scholar
• Hallengärd D, Haller BK, Maltais AK, Gelius E, Nihlmark K, Wahren B, Bråve A. Comparison of plasmid vaccine immunization schedules using intradermal in vivo electroporation. Clin Vaccine Immunol 2011; 18:1577 - 81; http://dx.doi.org/10.1128/CVI.05045-11; PMID: 21752954
   PubMed Web of Science ®Google Scholar
• Montero-Julian FA, Brailly H, Sautès C, Joyeux I, Dorval T, Mosseri V, Yasukawa K, Wijdenes J, Adler A, Gorin I, et al. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family. Clin Cancer Res 1997; 3:1443 - 51; PMID: 9815830
   PubMed Web of Science ®Google Scholar
• Badoual C, Bouchaud G, Agueznay NelH, Mortier E, Hans S, Gey A, Fernani F, Peyrard S, -Puig PL, Bruneval P, et al. The soluble alpha chain of interleukin-15 receptor: a proinflammatory molecule associated with tumor progression in head and neck cancer. Cancer Res 2008; 68:3907 - 14; http://dx.doi.org/10.1158/0008-5472.CAN-07-6842; PMID: 18483276
   PubMed Web of Science ®Google Scholar
• Guerkov RE, Targoni OS, Kreher CR, Boehm BO, Herrera MT, Tary-Lehmann M, Lehmann PV, Schwander SK. Detection of low-frequency antigen-specific IL-10-producing CD4(+) T cells via ELISPOT in PBMC: cognate vs. nonspecific production of the cytokine. J Immunol Methods 2003; 279:111 - 21; http://dx.doi.org/10.1016/S0022-1759(03)00240-0; PMID: 12969552
   PubMed Web of Science ®Google Scholar
• Tartour E, Mosseri V, Jouffroy T, Deneux L, Jaulerry C, Brunin F, Fridman WH, Rodriguez J. Serum soluble interleukin-2 receptor concentrations as an independent prognostic marker in head and neck cancer. Lancet 2001; 357:1263 - 4; http://dx.doi.org/10.1016/S0140-6736(00)04420-2; PMID: 11418153
   PubMed Web of Science ®Google Scholar
• Ahlborg N, Axelsson B. Dual- and triple-color fluorospot. Methods Mol Biol 2012; 792:77 - 85; http://dx.doi.org/10.1007/978-1-61779-325-7_6; PMID: 21956502
   PubMedGoogle Scholar
• Smedman C, Ernemar T, Gudmundsdotter L, Gille-Johnson P, Somell A, Nihlmark K, Gårdlund B, Andersson J, Paulie S. FluoroSpot analysis of TLR-activated monocytes reveals several distinct cytokine secreting subpopulations. Scand J Immunol 2011; 75:249 - 58; http://dx.doi.org/10.1111/j.1365-3083.2011.02641.x; PMID: 21955279
   PubMed Web of Science ®Google Scholar
• Elrefaei M, McElroy MD, Preas CP, Hoh R, Deeks S, Martin J, Cao H. Central memory CD4+ T cell responses in chronic HIV infection are not restored by antiretroviral therapy. J Immunol 2004; 173:2184 - 9; PMID: 15265956
   PubMed Web of Science ®Google Scholar
• Divekar AA, Zaiss DM, Lee FE, Liu D, Topham DJ, Sijts AJ, Mosmann TR. Protein vaccines induce uncommitted IL-2-secreting human and mouse CD4 T cells, whereas infections induce more IFN-gamma-secreting cells. J Immunol 2006; 176:1465 - 73; PMID: 16424174
   PubMed Web of Science ®Google Scholar
• Galli G, Medini D, Borgogni E, Zedda L, Bardelli M, Malzone C, Nuti S, Tavarini S, Sammicheli C, Hilbert AK, et al. Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels. Proc Natl Acad Sci U S A 2009; 106:3877 - 82; http://dx.doi.org/10.1073/pnas.0813390106; PMID: 19237568
   PubMed Web of Science ®Google Scholar
• Powers DC, McElhaney JE, Florendo OA Jr., Manning MC, Upshaw CM, Bentley DW, Wilkinson BE. Humoral and cellular immune responses following vaccination with purified recombinant hemagglutinin from influenza A (H3N2) virus. J Infect Dis 1997; 175:342 - 51; http://dx.doi.org/10.1093/infdis/175.2.342; PMID: 9203655
   PubMed Web of Science ®Google Scholar
• Flynn JK, Dore GJ, Hellard M, Yeung B, Rawlinson WD, White PA, Kaldor JM, Lloyd AR, Ffrench RA, ATAHC Study Group. Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users. J Viral Hepat 2011; 18:549 - 61; http://dx.doi.org/10.1111/j.1365-2893.2010.01335.x; PMID: 20626625
   PubMed Web of Science ®Google Scholar
• Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001; 194:1395 - 406; http://dx.doi.org/10.1084/jem.194.10.1395; PMID: 11714747
   PubMed Web of Science ®Google Scholar
• Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 2008; 8:247 - 58; http://dx.doi.org/10.1038/nri2274; PMID: 18323851
   PubMed Web of Science ®Google Scholar
• Harari A, Dutoit V, Cellerai C, Bart PA, Du Pasquier RA, Pantaleo G. Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev 2006; 211:236 - 54; http://dx.doi.org/10.1111/j.0105-2896.2006.00395.x; PMID: 16824132
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708 - 12; http://dx.doi.org/10.1038/44385; PMID: 10537110
   PubMed Web of Science ®Google Scholar
• Kannanganat S, Ibegbu C, Chennareddi L, Robinson HL, Amara RR. Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J Virol 2007; 81:8468 - 76; http://dx.doi.org/10.1128/JVI.00228-07; PMID: 17553885
   PubMed Web of Science ®Google Scholar
• Lucas M, Day CL, Wyer JR, Cunliffe SL, Loughry A, McMichael AJ, Klenerman P. Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells. J Virol 2004; 78:7284 - 7; http://dx.doi.org/10.1128/JVI.78.13.7284-7287.2004; PMID: 15194806
   PubMed Web of Science ®Google Scholar
• Danke NA, Kwok WW. HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination. J Immunol 2003; 171:3163 - 9; PMID: 12960344
   PubMed Web of Science ®Google Scholar
• Chapman TJ, Castrucci MR, Padrick RC, Bradley LM, Topham DJ. Antigen-specific and non-specific CD4+ T cell recruitment and proliferation during influenza infection. Virology 2005; 340:296 - 306; http://dx.doi.org/10.1016/j.virol.2005.06.023; PMID: 16054188
   PubMed Web of Science ®Google Scholar
• Lichterfeld M, Yu XG, Mui SK, Williams KL, Trocha A, Brockman MA, Allgaier RL, Waring MT, Koibuchi T, Johnston MN, et al. Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection. J Virol 2007; 81:4199 - 214; http://dx.doi.org/10.1128/JVI.01388-06; PMID: 17287271
   PubMed Web of Science ®Google Scholar
• Younes SA, Yassine-Diab B, Dumont AR, Boulassel MR, Grossman Z, Routy JP, Sekaly RP. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J Exp Med 2003; 198:1909 - 22; http://dx.doi.org/10.1084/jem.20031598; PMID: 14676302
   PubMed Web of Science ®Google Scholar
• Blattman JN, Grayson JM, Wherry EJ, Kaech SM, Smith KA, Ahmed R. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat Med 2003; 9:540 - 7; http://dx.doi.org/10.1038/nm866; PMID: 12692546
   PubMed Web of Science ®Google Scholar
• Zimmerli SC, Harari A, Cellerai C, Vallelian F, Bart PA, Pantaleo G. HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc Natl Acad Sci U S A 2005; 102:7239 - 44; http://dx.doi.org/10.1073/pnas.0502393102; PMID: 15872023
   PubMed Web of Science ®Google Scholar
• Pedersen GK, Madhun AS, Breakwell L, Hoschler K, Sjursen H, Pathirana RD, Goudsmit J, Cox RJ. T-helper 1 cells elicited by H5N1 vaccination predict seroprotection. J Infect Dis 2012; 206:158 - 66; http://dx.doi.org/10.1093/infdis/jis330; PMID: 22551811
   PubMed Web of Science ®Google Scholar
• Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K, Flavell R, Akira S, Ahmed R, Pulendran B. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 2006; 203:413 - 24; http://dx.doi.org/10.1084/jem.20051720; PMID: 16461338
   PubMed Web of Science ®Google Scholar
• Pulendran B, Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell 2006; 124:849 - 63; http://dx.doi.org/10.1016/j.cell.2006.02.019; PMID: 16497593
   PubMed Web of Science ®Google Scholar
• Ndongala ML, Kamya P, Boulet S, Peretz Y, Rouleau D, Tremblay C, Leblanc R, Côté P, Baril JG, Thomas R, et al. Changes in function of HIV-specific T-cell responses with increasing time from infection. Viral Immunol 2010; 23:159 - 68; http://dx.doi.org/10.1089/vim.2009.0084; PMID: 20373996
   PubMed Web of Science ®Google Scholar
• Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 2003; 77:4911 - 27; http://dx.doi.org/10.1128/JVI.77.8.4911-4927.2003; PMID: 12663797
   PubMed Web of Science ®Google Scholar
• Agarwal N, Ollington K, Kaneshiro M, Frenck R, Melmed GY. Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review. Vaccine 2012; 30:1413 - 24; http://dx.doi.org/10.1016/j.vaccine.2011.11.109; PMID: 22197580
   PubMed Web of Science ®Google Scholar
• Hillaire ML, Osterhaus AD, Rimmelzwaan GF. Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines. J Biomed Biotechnol 2011; 2011:939860; http://dx.doi.org/10.1155/2011/939860; PMID: 22007149
   PubMed Web of Science ®Google Scholar
• Lee RS, Tartour E, van der Bruggen P, Vantomme V, Joyeux I, Goud B, Fridman WH, Johannes L. Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin. Eur J Immunol 1998; 28:2726 - 37; http://dx.doi.org/10.1002/(SICI)1521-4141(199809)28:09<2726::AID-IMMU2726>3.0.CO;2-W; PMID: 9754560
   PubMed Web of Science ®Google Scholar
• Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC, Lambkin-Williams R, Gilbert A, Oxford J, Nicholas B, et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 2012; 18:274 - 80; http://dx.doi.org/10.1038/nm.2612; PMID: 22286307
   PubMed Web of Science ®Google Scholar
• Gey A, Hamdi S, Vielh P, Mehtali M, Fridman WH, Tartour E. Development of a direct in situ RT-PCR method using labeled primers to detect cytokine mRNA inside cells. J Immunol Methods 1999; 227:149 - 60; http://dx.doi.org/10.1016/S0022-1759(99)00078-2; PMID: 10485262
   PubMed Web of Science ®Google Scholar
• Levings MK, Gregori S, Tresoldi E, Cazzaniga S, Bonini C, Roncarolo MG. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 2005; 105:1162 - 9; http://dx.doi.org/10.1182/blood-2004-03-1211; PMID: 15479730
   PubMed Web of Science ®Google Scholar